| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate |
2013-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2676041dde83664fdeffe47e77d65d6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9885324dc50fc6f6b02130893cf37154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38601f407970cc697b45021b3b5d5f89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01767e906afeea44c70a853ac3b2c1ae |
| publicationDate |
2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2014087335-A |
| titleOfInvention |
SPINK1 and its use as a prostate cancer marker |
| abstract |
Compositions and methods for cancer research, diagnosis, and treatment, including but not limited to cancer markers. In particular, SPINK1 and other markers for prostate cancer are provided. (A) providing a sample containing prostate cells from a patient; (b) detecting overexpression of SPINK1 compared to normal expression of SPINK1 in a sample containing prostate cells; and c) A method for identifying prostate cancer in a patient comprising detecting normal expression of ERG and / or ETV1 in a sample containing prostate cells, wherein the ERG and / or in a sample containing prostate cells Alternatively, a method of identifying prostate cancer in a patient by detecting mutually exclusive overexpression of SPINK1 compared to normal expression of ETV1. [Selection figure] None |
| priorityDate |
2006-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |